Back to search

Aristotle University Of Thessaloniki (AUTH)

Η επίδραση του pembrolizumab στην επούλωση αναστομώσεων του παχέος εντέρου σε επίμυες

Abstract

dc:description

Background: Pembrolizumab is a monoclonal antibody that targets the Programmed cell death-1 (PD-1) protein. Blocking this pathway alters T-cell activity and has been approved for the treatment of several malignancies, including microsatellite instability–high (MSI-H) and mismatch repair–deficient (dMMR) colorectal cancers. The aim of this study was to evaluate the effect of Pembrolizumab on colonic anastomotic healing in a rat model. Methods: Sixty male Wistar rats were randomly divided into two groups of 30: a control group and an experimental group receiving Pembrolizumab. Each group was further divided into three subgroups of 10 rats, which were sacrificed on postoperative day (POD) 3, 7, or 14. All animals underwent laparotomy, a one-centimeter segmental colectomy, and an end-to-end colonic anastomosis. Post-mortem evaluation included measuring anastomotic bursting pressure, tissue hydroxyproline levels, and histopathological assessment. Results: A statistically significant difference in bursting pressure (BP, P = 0.019) and rupture site (P = 0.033) was observed between the groups on POD 7. Tissue hydroxyproline levels were significantly lower in the Pembrolizumab-treated subgroups on POD 7 (P = 0.003) and POD 14 (P = 0.001). Histopathological analysis demonstrated significant differences on POD 3 in neovascularization (P = 0.026), fibroblast ingrowth (P = 0.005), and collagen deposition (P = 0.030), suggesting impaired inflammatory-phase healing. Conclusion: This experimental study suggests that a high single dose of Pembrolizumab may negatively affect colonic anastomotic healing in rats. Further studies are necessary to determine the safety of intestinal anastomosis in both emergency and elective clinical settings.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Symeonidou, Elissavet
  • Συμεωνίδου, Ελισσάβετ

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61691

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Symeonidou, Elissavet; Συμεωνίδου, Ελισσάβετ. Η επίδραση του pembrolizumab στην επούλωση αναστομώσεων του παχέος εντέρου σε επίμυες. Aristotle University Of Thessaloniki (AUTH), 2026. http://hdl.handle.net/10442/hedi/61691